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The interaction of Solifenacin succinate (SFS) with bovine serum albumin (BSA) has been investigated by UV-visible 
spectrophotometric, spectrofluorometric viscometric and molecular modeling methods. Fluorescence spectra suggested that 
the quenching mechanism of the interaction of SFS to BSA was a static quenching type. By the analysis of UV/vis spectra, it 
was observed that SFS had a high affinity with BSA which was indicated by the large binding constant. The thermodynamic 
parameters, ΔH and ΔS for the interaction of SFS and BSA have been calculated at different temperatures. The 
thermodynamic studies suggested that the interaction processes were endothermic disfavoured (ΔH > 0) and entropy 
favoured (ΔS > 0), which indicated that the SFS might interact with BSA by a non-traditional intercalation mode of binding 
via hydrophobic force. Moreover, the results obtained from molecular docking corroborate the experimental results obtained 
from spectroscopic investigations.  
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Solifenacin succinate is an orally administered 
urinary antispasmodic anticholinergic drug.  
The chemical name of Solifenacin succinate is  
1-Azabicyclo[2.2.2]octan-8yl (1S)-1-phenyl-3,4-
dihydro-1H-isoquinoline-2-carboxylate butanedioic 
acid (Fig. 1)1. Solifenacin is a competitive muscarinic 
acetylcholine receptor antagonist. The binding of 
acetylcholine to these receptors, particularly the M3 
receptor sub type, plays a critical role in the 
contraction of the smooth muscle. By preventing the 
binding of acetylcholine to these receptors, 
solifenacin reduces the smooth muscle tone in the 
bladder, allowing the bladder to retain larger volumes 
of urine and reducing the number of micturition, 
urgency and incontinence episodes2,3. A literature 
survey reveals one HPLC4, one mass spectrometry5 
and one spectrophotometric method6 for the assay of 
SFS. There has not any report about the interaction 
study of SFS with BSA based on spectroscopic 
behaviour and molecular modeling.  
The binding mechanism of proteins with ligands 
from last few years have shed light on different areas 
of research and its important applications in numerous 
fields of science, such as the development of new 
biomaterials, biochemistry, food chemistry or 
pharmaceutical sciences7,8. The nature of interaction 
between the drug molecule and protein gives new 
opportunity for the development of new drugs. Since 
drugs are the compounds which are carried by 
albumin, it is necessary to study the interaction of 
new drug with protein9. Serum albumins are a model 
globular protein which plays a key role for acting as a 
carrier for several endogenous compounds. It has 
proved the most valuable invented globular proteins, 
used for transportation and metabolism of many 
biologically active compounds in the body10.  
Serum albumin has a well-established structure, 
having physicochemical properties, a versatile 
binding capacity stability and water solubility11. In the 
present scenario bovine serum albumin (BSA) has 






Fig. 1 — Chemical structure of Solifenacin Succinate 




presence in blood plasma of animals. It consist a 
single polypeptide chain of 583 amino acids and 
contains 17 cysteine residues (eight disulfide bonds 
and one free thiol). It is divided into three specific 
binding sites (I, II and III) for high-affinity of drugs. 
Every sites is consists of two subdomains (A and B). 
Human serum albumin (HSA) contributes about 80% 
of the osmotic pressure of blood12. It bears residue of 
585 amino acids with molar mass of 66,411 g mol-1 
having 17 disulfide bridges and free thiol (SH) group. 
Moreover, HSA consist of single tryptophan (TRP 
214) present in subdomain IIA13. The theme has a 
better insight for research fields such as clinical 
medicine, chemistry and life sciences. 
In the present work, the interaction of SFS  
with BSA has been investigated under imitated 
physiological conditions (pH 7.4) via ultraviolet-
visible, fluorescence, viscometric and molecular 
modeling techniques. The binding constants,  
number of binding sites and thermodynamic 
parameters have been calculated and the binding site 
of SFS on BSA was identified by fluorescence 
displacement experiments. Moreover, the molecular 
modeling was used to improve the understanding  
of the interaction of SFS with BSA. These results 
should be useful for understanding the interaction of 
SFS with BSA at the molecular level and be useful for 
the design of new drugs. 
 
Materials and Methods 
 
Chemicals and Materials 
A stock solution 1  103 mol L1 of SFS was 
prepared by dissolving its powder in double distilled 
water. BSA was purchased from S. D. fine-chem 
Limited and its stock solution was prepared by 
dissolving an appropriate amount in distilled water 
and stored at 4C. A buffer solution of pH 7.4 was 
prepared by following the standard methods. All other 
chemicals used were of analytical reagent grade. 
Doubly distilled deionised water was used throughout. 
 
Instrumentation 
UV-vis absorption spectra were measured by using 
Ellico UV-visible spectrophotometer (INDIA) and 
Fluorescence measurements were performed by using 
Hitachi F4500 spectrofluorimeter (JAPAN) equipped 
with a 150W Xenon lamp and 1 cm quartz cell.  
The widths of excitation and emission slits were set at 
5.0 and 10 nm, respectively, and the scan rate was 
1200 nm min1. The viscosity measurements were 
carried out using Ostwald viscometer. The pH 
measurements were made with Scott Gerate pH meter 
CG 804. An electronic thermostat water-bath was 
used for controlling the temperature. Molecular 
Docking Study of Solifenacin with Bovine serum 
albumin was performed with flexible molecular 
docking program Surflex-Dock implemented in sybyl-
X v1.2. Target protein structure of Bovine serum 
albumin was retrieved from protein database of PDB 
ID:4F5S. The protein preparation was carried out by 
two steps, preparation and refinement. After ensuring 
chemical correctness, water molecules in the crystal 
structures were deleted and hydrogens were added 
where hydrogen atoms were missing. Using the 
AMBER FF99 force field energy of crystal structure 
was minimized. Protomol were defined centering 
them on the ligand in the crystal structure using the 
default box size. The solifenacin ligands were built 
using Sybyl build panel and minimized using tripos 
force field then docked into binding site of Bovine 
serum albumin protein.  
 
Results and Discussion 
 
UV-Visible Spectroscopic study 
Figure 2 showed the UV/vis absorption spectra of 
SFS in the absence and presence of different 
concentrations of BSA. The maximum absorbance of 
SFS was located at around 256 nm. It was observed 
that on the addition of BSA, SFS showed an increase 
in molar absorptivity with a red shift. This 
hypochromic effect is thought to be due to the 
properties of BSA-drug interaction which are  
closely related with double helix structure14.  
 
 
Fig. 2 — UV-visible spectra of (a) 1  104 M SFS in the absence
of BSA and in presence of CBSA= 2.0, 4.0, 6.0, 8.0, 10.0,
12.0 µML1 of BSA (b to g) in PBS buffer of pH 7.4 




The hyperchromism which indicates a strong 
interaction between the electronic ground states of 
SFS with BSA and changes in the absorption bands 
and small bathochromic shifts shows that the binding 
between SFS and BSA was intercalation mode15. 
Generally, the red shift (or blue shift), hyperchromic 
(or hypochromic) changes in absorbance and 
wavelength shifts of this characteristic band reflect 
the corresponding structural changes of the BSA, 
including changes of stacking pattern, disruption  
of the hydrogen bonds between complementary 
strands, covalent binding of BSA bases, intercalation 
between aromatic rings of molecules, etc16-19. The 
hyperchromic effect and bathochromic shift indicates 
that to confirm the changes of BSA double helix 
structure after interacting with the SFS and observing 
the non-traditional intercalating mode.  
Based on the variations in the absorbance spectra 
of SFS upon binding to BSA, the binding constant (K) 


















           … (1) 
Where, A0 and A are the absorbances of drug in the 
absence and presence of BSA, εG and εH–G are the 
absorption coefficients of drug and its complex with 
BSA, respectively. The plot of A0/(A-A0) versus 
1/[BSA] was constructed using the data from the 
absorbance titrations was shown in Fig. 3)  
From the linear fitting, the binding constant (K) 
can be estimated from the ratio of the intercept to the 
slope. With this procedure, we calculated K = 2.253  
105 M1. It is seen that the fitting is good linear and 
the value of K determined here is consistent with that 
reported for the BSA binding to SFS (K ≈ 103 - 105)20. 
This indicates that the SFS display a relative high 
affinity with BSA21. 
 
Thermodynamic parameters and nature of Binding forces 
The interactions forces between drugs and 
biomolecules may include electrostatic interactions, 
multiple hydrogen bonds, van der Waals interactions, 
hydrophobic, steric contacts within the antibody-
binding site, etc. In order to elucidate the interaction 
of SFS with BSA, the thermodynamic parameters 
were calculated from the van’t Hoff plots. 
Thermodynamic parameters are employed in 
different temperatures to analyze the acting forces 
between SFS and BSA. The binding forces between 
drugs and biomolecules mainly include electrostatic 
interaction, hydrogen bond, van der Waals interaction, 
and hydrophobic interaction22. The different drugs may 
have different types of binding forces on interaction of 
protein. Thermodynamic parameters, free energy 
change (ΔG), enthalpy change (ΔH) and entropy 
change (ΔS) of interaction are essential to interpret the 
binding mode of BSA-drug complexes. When the 
temperature does not vary significantly, the reaction 
enthalpy can be considered as a constant. Its value can 
be evaluated from the Clausius-Clapeyron Eqs: 
ln (K2/K1)  = - ∆H /R [(1/T2) - (1/T1)]          ... (2) 
∆G  = - RT ln K                                         ... (3) 
∆G  = ∆H – T∆S                                        … (4) 
where, R is the gas constant, T is the experimental 
temperature, and K is the binding constant at the 
corresponding T. The Gibbs free energy change (ΔG) 
and the entropy change (ΔS) can be obtained from 
Eqs. 3 and 4, respectively. The value of ΔH can be 
calculated from the slope and intercept of the 
regression curve of ln K vs. 1/T, ΔG and ΔS values 
are consequently obtained according to (3) and (4), 
respectively. The values of ΔH, ΔS and ΔG for  
the interaction of SFS with BSA are presented in 
Table 1. The value of free energy (ΔG) of the 
Table 1 — Binding constants and thermodynamic parameters for the interaction of SFS and BSA 
Temperature in K Binding constant (Kb) ∆H (J mol1 ) ∆G (J mol1 ) ∆S (J mol1 K1) R
2 
287 1.1025  105  1.205  103 133.38 0.99673 
297 6.3822  105 37.077  103 22.888  103 195.32 0.99681 
307 2.2528  105  11.452  103 163.39 0.99773 
 
 
Fig. 3 — Plot of (A0 / (A-A0) versus 1/ [BSA] for SFS-BSA system 




interaction between SFS and BSA at different 
temperature (287, 297 and 307 K) were all negative, 
which revealed that the processes of the interaction 
between SFS and BSA was spontaneous. The values 
of ΔH and ΔS suggested that the interaction process 
was endothermic disfavoured (ΔH > 0) and entropy 
favoured (ΔS > 0). When ΔH < 0 or ΔH ≈ 0, ΔS > 0, 
the mainly acting force is electrostatic; when ΔH < 0, 
ΔS < 0, the mainly acting force is van der Waals or 
hydrogen bond and when ΔH > 0, ΔS > 0, the mainly 
force is hydrophobic. For the binding system of  
SFS with BSA, the ΔH and ΔS values were  
positive. Therefore, in the case of the present  
system, we presumed that hydrophobic interaction 
might be the main acting force in the binding  
of the SFS and BSA. If ΔG < 0 indicates the binding 
process is spontaneous, ΔS > 0 is an evidence  
of hydrophobic interactions23,24. Therefore, the 
hydrophobic interaction might play a major role in the 
interaction of SFS with BSA. 
 
Spectrofluorimetric study  
The fluorescence spectra of SFS in presence of 
different concentrations of BSA are shown in (Fig. 4). 
SFS shows strong fluorescence emission peak  
at 460 nm and the fluorescence intensity increases 
gradually with increasing concentration of BSA, 
which indicates that BSA can interact with SFS and 
quench its intrinsic fluorescence. Furthermore,  
there is a slight red shift of maximum emission 
wavelength occurring with the addition of BSA, 
implying that the microenvironment around the 
chromophore of SFS is changed. The fluorescence 
intensity increases due to increase in the molecular 
planarity of the complex and decreases the collision 
frequency of solvent molecules with SFS. This is due 
to diffusion which occurs between adjacent base pairs 
of BSA25. The binding constant was calculated 
according to Stern-Volmer Eq.: 
Fo/ F = 1+ kq τo [Q] = 1 + Ksv [Q]              … (5) 
where, Fo and F are the fluorescence intensities in 
absence and presence of BSA, respectively, [Q] is the 
concentration of quencher, kq is the quenching rate 
constant, τo is the average life time of biomolecule 
without quencher and its value 108 s and Ksv is the 
Stern-Volmer quenching constant. The values of Ksv 
and Kq can be determined from the slope of regression 
curve Fo/F vs. [Q] (Fig. 5).  
The binding constant Ksv and Kq values calculated 
were found to be 7.273  104 L mol1 and 7.273  
1012 L mol1 s1 ( R2 = 0.99876), respectively. The 
maximum rate constant of collisional quenching Kq of 
various quenchers with biopolymers26 is about 2.0  
1010 L mol1 s1, which suggests that the fluorescence 
quenching process may be mainly controlled by static 
quenching mechanism rather than dynamic.  
 
The Binding Constant and Number of Binding Sites  
The binding constant and number of binding sites 
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where, Kb is binding constant and n is number of 
binding sites in base pair units, respectively. The 
 
 
Fig. 4 — Fluorescence spectra of a) 1.5  104 M SFS in
the absence of BSA and the presence of CBSA= 5.0, 10.0, 15.0,




Fig. 5 — Stern-volmer plot of (F0 / F) vs [Q] for SFS-BSA system 




values of n and Kb can be determined from the slope 
and intercept of the double logarithm regression curve 
(log [(F0 - F)/F] vs log [Q]) (Fig. 6). The binding 
constant value 3.794  104 L mol1 (R2 = 0.99879) 
and values of n approximately equal to unity, 
indicating that there is one independent class of 
binding sites in BSA for SFS. 
 
Viscosity Measurements 
Viscosity experiment is an effective tool to study 
the binding mode of small molecules to BSA. The 
interaction between SFS and BSA, we carried out 
viscosity measurements at room temperature. A 
classical intercalation binding demands the space 
adjacent base pairs to be large enough to 
accommodate the bound ligand and elongate the 
double helix, resulting in an increase of BSA  
viscosity while a non-classical intercalation or a 
groove mode would reduce the BSA viscosity28. The 
viscosity measurements were taken by varying the 
concentration ratio of BSA and SFS. The values of 
relative specific viscosity (η/η0)
1/3 vs. [SFS] / [BSA] 
were plotted in the absence and presence of BSA as 
shown in (Fig. 7).  
It was observed that, the relative specific 
viscosities of BSA exhibited a dependence on the 
concentration of SFS, which increases with the value 
of [SFS]/[BSA]. The behaviour indicates that non-
classical intercalation mode of binding and possibly a 
groove binding via hydrophobic interaction between 
SFS with BSA. 
 
Molecular modeling of Solifenacin succinate with Bovine 
serum albumin 
To investigate the detailed intermolecular 
interactions between the ligand and the target protein 
docking studies was carried out using Sybyl-X v1.2. 
Molecular Docking Study of SFS with BSA was 
performed with flexible molecular docking program 
Surflex-Dock implemented in sybyl-X v1.2.  
Surflex-Dock uses an empirical scoring function 
(based on the Hammerhead docking system) that  
has been updated and re-parameterized with 
additional negative training data5, along with a search 
engine that relies on a surface based molecular 
similarity method. 
The Docked conformation of the most active pose 
of SFS in binding site shows total docking score of 
4.0428. Docking pose of compound showing 
hydrophobic interactions with receptor active site 
residues PHE 501, LEU505, LEU531, ALA527, GLN 
579 (Fig. 8). Hydrophobic interaction play important 
role in binding of SFS with BSA (Fig. 9). 
 
 
Fig. 6 — Plot of log [(F0 - F)/F] vs log [Q] for SFS-BSA system 
 
 
Fig. 7 — Effect of increasing the concentration of BSA on the




Fig. 8 — Amino acid residues involved in the binding of
SFS to BSA 





Interaction mechanism of SFS with BSA has been 
investigated by fluorescence spectroscopic, UV-vis 
spectroscopic, Viscometric methods and molecular 
modeling techniques. The results show that SFS interact 
with BSA by a non-traditional intercalation mode via 
hydrophobic force. The thermodynamic studies 
suggested that the binding between BSA and SFS is 
spontaneous (ΔG < 0). The binding process is 
endothermic disfavoured (ΔH > 0) and entropy is 
favoured (ΔS > 0), this is the evidence of main 
interaction forces are hydrophobic forces accompanied 
by hydrogen bonds and electrostatic interactions. The 
molecular modeling results revealed that intercalated 
mechanism is followed by SFS to bind with BSA and 
thus will be very helpful to the design of new drug. 
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